Cargando…

Metabolic and Biochemical Stressors in Diabetic Cardiomyopathy

Diabetic cardiomyopathy (DCM) or diabetes-induced cardiac dysfunction is a direct consequence of uncontrolled metabolic syndrome and is widespread in US population and worldwide. Despite of the heterogeneous and distinct features of DCM, the clinical relevance of DCM is now becoming established. DCM...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kain, Vasundhara, Halade, Ganesh V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5449449/ https://www.ncbi.nlm.nih.gov/pubmed/28620607 http://dx.doi.org/10.3389/fcvm.2017.00031

Ejemplares similares

Heart Failure Syndrome With Preserved Ejection Fraction Is a Metabolic Cluster of Non-resolving Inflammation in Obesity
por: Tourki, Bochra, et al.
Publicado: (2021)

Inflammation in Metabolic Cardiomyopathy
por: Wenzl, Florian A., et al.
Publicado: (2021)

Proteomic Analysis Suggests Altered Mitochondrial Metabolic Profile Associated With Diabetic Cardiomyopathy
por: Gomes, Karina P., et al.
Publicado: (2022)

Activation of EP4 receptor limits transition of acute to chronic heart failure in lipoxygenase deficient mice
por: Kain, Vasundhara, et al.
Publicado: (2021)

Molecular and Cellular Differences in Cardiac Repair of Male and Female Mice
por: Pullen, Amanda B., et al.
Publicado: (2020)

Bibliometric analysis of the inflammation in diabetic cardiomyopathy
por: Zhu, Ning, et al.
Publicado: (2022)

Editorial: Metabolic Related Cardiomyopathy in Hyperglycemic Patients
por: Capuano, Annalisa, et al.
Publicado: (2022)

The multifaceted roles of ER and Golgi in metabolic cardiomyopathy
por: Raja, Rida, et al.
Publicado: (2022)

Mitochondrial ROS Formation in the Pathogenesis of Diabetic Cardiomyopathy
por: Kaludercic, Nina, et al.
Publicado: (2020)

Molecular Mechanisms and Epigenetic Regulation in Diabetic Cardiomyopathy
por: Mittal, Anupam, et al.
Publicado: (2021)

Novel Insights Into the Pathogenesis of Diabetic Cardiomyopathy and Pharmacological Strategies
por: Muñoz-Córdova, Felipe, et al.
Publicado: (2021)

Editorial: Understanding Molecular Mechanisms in Diabetic Cardiomyopathy (DCM)
por: Muthu, Sakthijothi, et al.
Publicado: (2022)

Targeting lipid metabolism as a new therapeutic strategy for inherited cardiomyopathies
por: Gaar-Humphreys, Karen R., et al.
Publicado: (2023)

Left Ventricular Hypertrophy in Diabetic Cardiomyopathy: A Target for Intervention
por: Mohan, Mohapradeep, et al.
Publicado: (2021)

Research('s) Sweet Hearts: Experimental Biomedical Models of Diabetic Cardiomyopathy
por: Richter, Claudia, et al.
Publicado: (2021)

Skeletal Muscle Microvascular Dysfunction Manifests Early in Diabetic Cardiomyopathy
por: Loai, Sadi, et al.
Publicado: (2021)

Screening of Lipid Metabolism-Related Gene Diagnostic Signature for Patients With Dilated Cardiomyopathy
por: Xu, Man, et al.
Publicado: (2022)

Transcriptome data analysis of primary cardiomyopathies reveals perturbations in arachidonic acid metabolism
por: Chauhan, Pankaj Kumar, et al.
Publicado: (2023)

Cellular Protein Quality Control in Diabetic Cardiomyopathy: From Bench to Bedside
por: Kaur, Namrita, et al.
Publicado: (2020)

Galectin-3 Inhibition Ameliorates Streptozotocin-Induced Diabetic Cardiomyopathy in Mice
por: Zhu, Ning, et al.
Publicado: (2022)

Potential diabetic cardiomyopathy therapies targeting pyroptosis: A mini review
por: Jia, Yu, et al.
Publicado: (2022)

Aging dysregulates D- and E-series resolvins to modulate cardiosplenic and cardiorenal network following myocardial infarction
por: Halade, Ganesh V., et al.
Publicado: (2016)

Nomogram based on multimodal echocardiography for assessing the evolution of diabetic cardiomyopathy in diabetic patients with normal cardiac function
por: Liu, Yi, et al.
Publicado: (2022)

The Potential of Metabolism-Related Gene OGDHL as a Biomarker for Myocardial Remodeling in Dilated Cardiomyopathy
por: Tang, Yaohan, et al.
Publicado: (2022)

Long Non-coding RNA: A Key Regulator in the Pathogenesis of Diabetic Cardiomyopathy
por: Guo, Yaoyao, et al.
Publicado: (2021)

Adropin Alleviates Myocardial Fibrosis in Diabetic Cardiomyopathy Rats: A Preliminary Study
por: Liu, Mao, et al.
Publicado: (2021)

Mitochondrial Arrest on the Microtubule Highway—A Feature of Heart Failure and Diabetic Cardiomyopathy?
por: Kassab, Sarah, et al.
Publicado: (2021)

Ferroptosis, necroptosis and cuproptosis: Novel forms of regulated cell death in diabetic cardiomyopathy
por: Ke, Dan, et al.
Publicado: (2023)

Mitochondrial Cardiomyopathies
por: El-Hattab, Ayman W., et al.
Publicado: (2016)

Identification and Analysis of Hub Genes in Diabetic Cardiomyopathy: Potential Role of Cytochrome P450 1A1 in Mitochondrial Metabolism and STZ-Induced Myocardial Dysfunction
por: Chen, Yinliang, et al.
Publicado: (2022)

Proteomic and metabolomic analyses reveal the novel targets of spermine for alleviating diabetic cardiomyopathy in type II diabetic mice
por: Sun, Jian, et al.
Publicado: (2022)

Plasma Metabolomic Profiles Differentiate Patients With Dilated Cardiomyopathy and Ischemic Cardiomyopathy
por: Zhao, Junhan, et al.
Publicado: (2020)

Analysis of Selected Cardiovascular Biomarkers in Takotsubo Cardiomyopathy and the Most Frequent Cardiomyopathies
por: Topf, Albert, et al.
Publicado: (2021)

Shared Genetic Etiology of Primary Dilated Cardiomyopathy and Ischemic Dilated Cardiomyopathy
por: Sun, Yang, et al.
Publicado: (2021)

Traditional Chinese Medication Qiliqiangxin Attenuates Diabetic Cardiomyopathy via Activating PPARγ
por: Wu, Xiaodong, et al.
Publicado: (2021)

Hypoglycemia-Exacerbated Mitochondrial Connexin 43 Accumulation Aggravates Cardiac Dysfunction in Diabetic Cardiomyopathy
por: Wei, Xing, et al.
Publicado: (2022)

Effects of non-coding RNAs and RNA-binding proteins on mitochondrial dysfunction in diabetic cardiomyopathy
por: Potel, Koray N., et al.
Publicado: (2023)

Proteome-wide analysis of lysine β-hydroxybutyrylation in the myocardium of diabetic rat model with cardiomyopathy
por: Luo, Weiguang, et al.
Publicado: (2023)

COVID-19 in Adults With Hypertrophic Cardiomyopathy
por: Arabadjian, Milla E., et al.
Publicado: (2021)

Impact of Syndecan-2-Selected Mesenchymal Stromal Cells on the Early Onset of Diabetic Cardiomyopathy in Diabetic db/db Mice
por: Pappritz, Kathleen, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_m4nohgld7gdcafrnnc2eece011